Subbu Nambi
Stock Analyst at Guggenheim
(3.40)
# 1,248
Out of 5,182 analysts
76
Total ratings
46.27%
Success rate
5.72%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Maintains: Buy | $58 → $50 | $40.70 | +22.85% | 6 | Mar 30, 2026 | |
| BLLN BillionToOne | Maintains: Buy | $120 → $100 | $79.43 | +25.90% | 2 | Mar 30, 2026 | |
| GRAL GRAIL | Maintains: Buy | $130 → $75 | $51.71 | +45.04% | 4 | Mar 30, 2026 | |
| TEM Tempus AI | Maintains: Buy | $95 → $60 | $55.87 | +7.39% | 5 | Mar 30, 2026 | |
| TWST Twist Bioscience | Maintains: Buy | $50 → $55 | $59.81 | -8.04% | 4 | Mar 30, 2026 | |
| VCYT Veracyte | Maintains: Buy | $50 → $45 | $33.80 | +33.14% | 6 | Mar 30, 2026 | |
| WGS GeneDx Holdings | Maintains: Buy | $170 → $100 | $65.96 | +51.61% | 3 | Mar 30, 2026 | |
| NAUT Nautilus Biotechnology | Maintains: Buy | $2.5 → $4 | $3.03 | +32.01% | 2 | Feb 27, 2026 | |
| WAT Waters | Reiterates: Buy | $440 | $327.77 | +34.24% | 1 | Feb 10, 2026 | |
| SOPH SOPHiA GENETICS | Maintains: Buy | $6 → $7 | $5.28 | +32.58% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $13 | $6.73 | +93.16% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $144 → $170 | $134.50 | +26.39% | 5 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $135 | $90.36 | +49.40% | 8 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $47 | $25.05 | +87.62% | 3 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $21 | $14.47 | +45.13% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $9.51 | +26.18% | 4 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $270 | $208.40 | +29.56% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $275 | $194.75 | +41.21% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $93.96 | - | 1 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $21.15 | +70.21% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $10.35 | -3.38% | 1 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.08 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $26.08 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $131.21 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.69 | - | 1 | Dec 14, 2023 |
Bruker
Mar 30, 2026
Maintains: Buy
Price Target: $58 → $50
Current: $40.70
Upside: +22.85%
BillionToOne
Mar 30, 2026
Maintains: Buy
Price Target: $120 → $100
Current: $79.43
Upside: +25.90%
GRAIL
Mar 30, 2026
Maintains: Buy
Price Target: $130 → $75
Current: $51.71
Upside: +45.04%
Tempus AI
Mar 30, 2026
Maintains: Buy
Price Target: $95 → $60
Current: $55.87
Upside: +7.39%
Twist Bioscience
Mar 30, 2026
Maintains: Buy
Price Target: $50 → $55
Current: $59.81
Upside: -8.04%
Veracyte
Mar 30, 2026
Maintains: Buy
Price Target: $50 → $45
Current: $33.80
Upside: +33.14%
GeneDx Holdings
Mar 30, 2026
Maintains: Buy
Price Target: $170 → $100
Current: $65.96
Upside: +51.61%
Nautilus Biotechnology
Feb 27, 2026
Maintains: Buy
Price Target: $2.5 → $4
Current: $3.03
Upside: +32.01%
Waters
Feb 10, 2026
Reiterates: Buy
Price Target: $440
Current: $327.77
Upside: +34.24%
SOPHiA GENETICS
Jan 26, 2026
Maintains: Buy
Price Target: $6 → $7
Current: $5.28
Upside: +32.58%
Jan 26, 2026
Maintains: Buy
Price Target: $12 → $13
Current: $6.73
Upside: +93.16%
Jan 26, 2026
Maintains: Buy
Price Target: $144 → $170
Current: $134.50
Upside: +26.39%
Jan 26, 2026
Maintains: Buy
Price Target: $115 → $135
Current: $90.36
Upside: +49.40%
Jan 26, 2026
Maintains: Buy
Price Target: $43 → $47
Current: $25.05
Upside: +87.62%
Jan 26, 2026
Maintains: Buy
Price Target: $20 → $21
Current: $14.47
Upside: +45.13%
Jan 9, 2026
Maintains: Buy
Price Target: $8 → $12
Current: $9.51
Upside: +26.18%
Jan 5, 2026
Maintains: Buy
Price Target: $230 → $270
Current: $208.40
Upside: +29.56%
Jan 5, 2026
Maintains: Buy
Price Target: $250 → $275
Current: $194.75
Upside: +41.21%
Oct 16, 2025
Initiates: Neutral
Price Target: n/a
Current: $93.96
Upside: -
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $21.15
Upside: +70.21%
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $10.35
Upside: -3.38%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $5.08
Upside: -
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $26.08
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $131.21
Upside: -
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.69
Upside: -